Literature DB >> 3830711

Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.

B Brembilla-Perrot, P Admant, A Le Helloco, C Pernot.   

Abstract

Although anterograde conduction through a Kent bundle with a short refractory period was suppressed by 300 mg of flecainide acetate, the infusion of small amounts of isoproterenol caused the reappearance of WPW and permitted the induction of an atrial tachycardia with 1/1 conduction through the accessory pathway at a rate of 260 beats min-1. This case shows that the effect of isoproterenol may be maintained after apparently successful flecainide therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3830711     DOI: 10.1093/oxfordjournals.eurheartj.a061812

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  2 in total

1.  Dose-dependent alteration of rat cardiac sodium current by isoproterenol: results from direct measurements on multicellular preparations.

Authors:  M Kirstein; R Eickhorn; K Kochsiek; H Langenfeld
Journal:  Pflugers Arch       Date:  1996-01       Impact factor: 3.657

2.  Electrophysiological evaluation of Wolff-Parkinson-White syndrome.

Authors:  Beatrice Brembilla-Perrot
Journal:  Indian Pacing Electrophysiol J       Date:  2002-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.